Xiaoliang Zheng

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Top Venues

OncoTargets and therapy

Disease markers

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nana Zhou, Chaoqin Guo, Jingyang Du, Xu Zhang, Qiuran Xu, Xiaoliang Zheng, Linglan Tu
TSC22D2 Regulates ACOT8 to Delay the Malignant Progression of Colorectal Cancer. OncoTargets and therapy 17 (2024)
Nana Zhou, Chaoqin Guo, Jingyang Du, Xu Zhang, Qiuran Xu, Xiaoliang Zheng, Linglan Tu
TSC22D2 Regulates ACOT8 to Delay the Malignant Progression of Colorectal Cancer. OncoTargets and therapy 17 (2024)
Xu Zhang, Linglan Tu, Haohuan Chai, Zilin Li, Yuhan Fu, Xiaoliang Zheng, Shenxin Zeng, Liyan Cheng
The Activity of Novel BCR-ABL Small-Molecule Degraders Containing Pyrimidine Rings and Their Role in Overcoming Drug Resistance. Journal of oncology 2022 (2022)
Yiyi Pu, Dongmei Yan, Linglan Tu, Liyan Cheng, Jie Yu, Zhuduo Li, Xiaoliang Zheng, Xinbao Wang
CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma Cells. Disease markers 2022 (2022)